Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
2
institutions
Market cap
$3.4B
54M shares
52-week range
$48.71 – $68.63
49% from low
Sector
ADHESIVES & SEALANTS
Exchange
NYSE
CS
Borrow rate
0.41%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.04B | $2.90B | $2.79B | $3.28B | $3.75B | $3.51B | $3.57B | $3.47B |
| Cost of revenue | $2.21B | $2.09B | $2.03B | $2.43B | $2.79B | $2.49B | $2.49B | $2.37B |
| Gross profit | $833.9M | $809.0M | $757.7M | $845.1M | $963.5M | $1.02B | $1.07B | $1.10B |
| Gross margin | 27.4% | 27.9% | 27.2% | 25.8% | 25.7% | 29.2% | 30.1% | 31.7% |
| R&D | $35.5M | $36.6M | $37.0M | $39.3M | $44.9M | $48.6M | $49.6M | $0 |
| Operating income | $246.8M | $240.5M | $222.9M | $255.7M | $322.3M | $379.5M | $368.9M | $399.1M |
| EBITDA | $412.8M | $417.3M | $383.9M | $438.1M | $490.4M | $528.6M | $490.5M | $527.1M |
| Net income | $171.2M | $130.8M | $123.7M | $161.4M | $180.3M | $144.9M | $130.3M | $152.0M |
| Net margin | 5.6% | 4.5% | 4.4% | 4.9% | 4.8% | 4.1% | 3.6% | 4.4% |
| EPS (diluted) | 3.29 | 2.52 | 2.36 | 2.97 | 3.26 | 2.59 | 2.30 | 2.75 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $3.6B | $4.85 | $4.71–$4.93 | 4 |
| 2027 | $3.8B | $5.29 | $4.86–$5.58 | 4 |
| 2028 | $4.0B | $5.84 | $5.63–$6.05 | 2 |
Forward consensus · source: Financial Modeling Prep
H.B. Fuller Co manufactures and sells adhesives, sealants, and other chemical-based products. The company organizes itself into three segments: Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. It generates the maximum revenue from hygiene, health, and consumable adhesives. This segment produces and supplies a full range of specialty industrial adhesives such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven, and hygiene (disposable diapers, feminine care, and medical garments) and health and beauty. The company generates around half of its revenue in the United States.
www.hbfuller.comNo one on the platform currently holds FUL.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-12-31 | 31,400 | $1.9M |
| Bridgewater Associatesas of 2026-03-31 | 12,466 | $768.9K |
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-30 | $0.2450 | 2026-05-14 |
| 2026-02-05 | $0.2350 | 2026-02-19 |
| 2025-10-16 | $0.2350 | 2025-10-30 |
| 2025-07-31 | $0.2350 | 2025-08-14 |
| 2025-04-29 | $0.2350 | 2025-05-13 |
| 2025-02-06 | $0.2225 | 2025-02-20 |
| 2024-10-17 | $0.2225 | 2024-10-31 |
| 2024-07-31 | $0.2225 | 2024-08-14 |
| 2024-04-24 | $0.2225 | 2024-05-09 |
| 2024-02-06 | $0.2050 | 2024-02-21 |
No one on the platform has traded FUL yet.
| $2.9B |
| — |
| OLNOlin Corporation | $20.09 | -3.51% | $2.3B | — |
| PRMPerimeter Solutions, Inc. | $33.30 | +1.74% | $5.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
| 2023-10-18 |
| $0.2050 |
| 2023-11-02 |
| 2023-07-19 | $0.2050 | 2023-08-03 |
| Execution date | Ratio |
|---|---|
| 2006-08-07 | 2-for-1 |
Trading at NaN× earnings vs its 23.3× historical median P/E.
Fair value ≈ $-10.50 · price $58.51 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$FUL Technology and semiconductor companies are executing strategic acquisitions to expand AI and edge computing capabilities, with Onsemi's $7 billion all-stock acquisition of Synaptics exemplifying consolidation around AI-enabled intelligent systems and edge computing platforms. Learn more: https://axlfi.com/themes/379
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-6-24-hb-fuller-stock/ $FUL H. B. Fuller Earnings Transcript
View on StockTwits ↗$FUL The Acquisition of Advanced Medical Solutions would broaden H.B. Fuller’s product portfolio and add a medical adhesives segment to its overall product offerings.
View on StockTwits ↗$FUL Q2 '26 Earnings Results & Recap H.B. Fuller now expects fiscal 2026 adjusted EBITDA to be in the range of $650 million to $675 million and adjusted EPS (diluted) in the range of $4.60 to $4.90, reflecting increased midpoints.
View on StockTwits ↗$FUL (-8.3% pre) H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions https://www.streetinsider.com/Mergers+and+Acquisitions/H.B.+Fuller+makes+%C2%A3715M+cash+offer+to+acquire+Advanced+Medical+Solutions/26687150.html
View on StockTwits ↗$FUL (-8.3% pre) .B. Fuller (FUL) Tops Q2 EPS by 3c; Offers Outlook https://ooc.bz/l/106192
View on StockTwits ↗HB Fuller Sees $55M Synergy Potential From AMS Deal – But Investors Are Still Selling FUL Stock $FUL https://stocktwits.com/news/equity/markets/ful-to-buy-ams-cash-deal-uk-tam-q2-earnings/cZ1Gh2sR7QH
View on StockTwits ↗$FUL reported 1.41 EPS and 950.27 revenue for Q2. http://www.estimize.com/intro/ful?chart=historical&metric_name=eps&utm_content=FUL&utm_me
View on StockTwits ↗$MLKN $TCOM $FUL $SPRY $TSHA AFTER-HOURS MOVERS: Currently Higher After Earnings: - Micron (MU) up 15.8%; - Other semis and memory names broadly up in sympathy: Lam Research (LRCX) up 7.0%, Rambus (RMBS) up 6.6%, Arm Holdings (ARM) up 7.2%, Sandisk (SNDK) up 12.3%, Western Digital (WDC) up 12.4%. - Methode Electronics, Inc. (MEI) up 13.4% Currently Also Higher: - Qualcomm (QCOM) up 13.0% after disclosing medium-term targets - NETSTREIT (NTST) up 3.1% after entering S&P SmallCap 600 index - FormFactor, Inc. (FORM) up 4.5% after being added to Russell 1000 index Currently Lower After Earnings: - MillerKnoll (MLKN) down 4.6% - Trip. com Group Limited (TCOM) down 3.5% - H.B. Fuller (FUL) down 2.9% - Jefferies (JEF) down 0.7% Currently Also Lower: - ARS Pharmaceuticals (SPRY) down 24.1% after commercial update on neffy - Taysha Gene Therapies (TSHA) down 9.2% after equity offering. - CG Oncology, Inc. (CGON) down 5.0% after block trade
View on StockTwits ↗$FUL H.B. Fuller sees Q3 revenue up mid-single digits Sees Q3 adjusted EBITDA $180M-$190M.
View on StockTwits ↗$FUL H.B. Fuller raises FY26 EPS view to $4.60-$4.90 from $4.55-$4.90, consensus $4.7 Backs FY26 revenue growth view mid-single digits.
View on StockTwits ↗$FUL H.B. Fuller reports Q2 adjusted EPS $1.41, consensus $1.38 Reports Q2 revenue $950M, consensus $924.79M. "We executed very well in the second quarter, delivering strong year-on-year revenue, EBITDA, and EPS growth, with results above the midpoint of our EBITDA guidance range," said Celeste Mastin, president and chief executive officer. "Our global sourcing capabilities and swift pricing actions have enabled us to maintain supply continuity and reliably serve our customers through market disruption. These efforts, combined with our Quantum Leap restructuring initiative, have strengthened our competitive position and we remain confident in our ability to deliver strong financial results."
View on StockTwits ↗$MU $JEF $FUL $MLKN Some notable companies reporting after the market close, with earnings consensus estimates: - Micron (MU), consensus $20.28 - Jefferies (JEF), consensus $1.24 - H.B. Fuller (FUL), consensus $1.38 - MillerKnoll (MLKN), consensus 51c
View on StockTwits ↗#earnings after the close on Wednesday, June 24, 2026, and before the open on Thursday, June 25, 2026 https://www.earningswhispers.com/calendar $MU $TCOM $BB $LOT $FUL
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.